secwatch / observer
8-K filed May 29, 2026, 4:46 PM ET CIK 0001851048
other material confidence medium sentiment negative materiality 0.60

Cyber App Solutions defers foreclosure on convertible notes to July 7, 2026

Cyber App Solutions Corp.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001851048-26-000008
form_type
8-K
ticker
null
cik
0001851048
company_name
Cyber App Solutions Corp.
filed_at
2026-05-29T20:46:03+00:00
discovered_at
2026-05-29T20:47:00.264830+00:00
generated_at
2026-05-29T20:47:07.583900+00:00
sec_items
["8.01"]
event_type
other_material
sentiment
negative
materiality_score
0.6
calibrated_materiality_score
0.6
confidence
medium
secwatch_canonical_url
https://secwatch.observer/filing/0001851048-26-000008
json_url
https://secwatch.observer/filing/0001851048-26-000008.json
markdown_url
https://secwatch.observer/filing/0001851048-26-000008.md
text_url
https://secwatch.observer/filing/0001851048-26-000008.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1851048/000185104826000008/0001851048-26-000008-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1851048/000185104826000008/form8kextension.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Comparable filings

EMYB

Embassy Bancorp expands stock repurchase program by additional $5M

Embassy Bancorp, Inc. June 1, 2026, 4:37 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

ORLY

O'Reilly Automotive adds $2.0B to share repurchase program, total authorized now $31.75B

O REILLY AUTOMOTIVE INC June 1, 2026, 4:31 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

XAIR

Beyond Air receives Nasdaq panel grant for continued listing; must meet bid price rule by July 31, 2026

Beyond Air, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

CTXR

Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned

Citius Pharmaceuticals, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

CTOR

Citius Oncology reports Phase 1 combo data for LYMPHIR in gynecologic cancers; 24% ORR, 33% in endometrial cancer

CITIUS ONCOLOGY, INC. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

NHI

NHI receives early HSR termination, anticipates July 1 closing of property sale to NHC subsidiary

NATIONAL HEALTH INVESTORS INC June 1, 2026, 4:15 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

SAM

Boston Beer annual meeting: say-on-pay fails, director Joyce sees majority withhold votes

BOSTON BEER CO INC June 1, 2026, 4:10 PM ET other_material Items 5.01, 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

SYRE

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001851048-26-000008

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.